1. Market Research
  2. > Biotechnology
  3. > Biological Therapy Market Trends
  4. > Biological Therapy Analysis & Statistics, February 2016 (p8)

Biological Therapy Analysis & Statistics, February 2016 (p8)

24/7 Customer Support

Talk to Ahmad

+44 207 1931 362

211-240 of about 1 000 reports

Purchase Reports From Reputable Market Research Publishers

Biosimilars in Oncology: Update Bulletin [Feb 2016]

Biosimilars in Oncology: Update Bulletin [Feb 2016]

  • € 945
  • Industry report
  • February 2016
  • by Firstword Pharma

New KOL insights on the latest events that have the potential to shape the oncology biosimilars market. Topics covered include opinions about data from Sandoz’s PROTECT 1 and PROTECT 2 studies which ...

  • Industries : Biopharmaceutical, Biotechnology, Pathology, Biological Therapy
  • Countries : Europe
Global Gene Therapy Partnering Terms and Agreements 2010 to 2016

Global Gene Therapy Partnering Terms and Agreements 2010 to 2016

  • € 1 596
  • Industry report
  • February 2016
  • by Currentpartnering

The Global Gene Therapy Partnering Agreements report provides an understanding and access to the gene therapy partnering deals and agreements entered into by the worlds leading healthcare companies. Trends ...

  • Industries : Biological Therapy, Drug Delivery Technology
  • Countries : World
B Cell Receptor Signaling Pathway in Oncology Drug Pipeline Update

B Cell Receptor Signaling Pathway in Oncology Drug Pipeline Update

  • € 2 250
  • Industry report
  • February 2016
  • by Bioseeker

Activation of the B cell receptor involves phosphorylation of the cytoplasmic immunoreceptor tyrosine-based activation motifs (ITAMs) present in Ig alpha and beta. This leads to activation of several non-recepto ...

  • Industries : Biological Therapy
RNAs (miRNA, RNAi & siRNA) in Oncology: Drug Pathway Analyzer

RNAs (miRNA, RNAi & siRNA) in Oncology: Drug Pathway Analyzer

  • € 750
  • Industry report
  • February 2016
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 92 RNA (miRNA, RNAi & siRNA) drugs known to affect more than 168 specific intracellular signaling pathways ...

  • Industries : Biological Therapy
RNA (miRNA, RNAi & siRNA) Therapy in Oncology Drug Pipeline Update

RNA (miRNA, RNAi & siRNA) Therapy in Oncology Drug Pipeline Update

  • € 1 495
  • Industry report
  • February 2016
  • by Bioseeker

Potentially any disease-causing gene, cell type or tissue can be targeted with miRNA, RNAi or siRNA, including those not ’druggable’ with small molecules or protein-based therapies. There are today ...

  • Industries : Biological Therapy
Nucleic Acid Therapies in Oncology Drug Pipeline Update

Nucleic Acid Therapies in Oncology Drug Pipeline Update

  • € 2 250
  • Industry report
  • February 2016
  • by Bioseeker

Nucleic acid therapies in oncology includes: Gene Therapy, DNA vaccine, Other DNA technologies, RNA Interference (RNAi), Small interfering RNA (siRNA), Antisense RNA and Ribozymes. There are today 299 ...

  • Industries : Biological Therapy
MicroRNAs in Cancer Drug Pipeline Update

MicroRNAs in Cancer Drug Pipeline Update

  • € 2 250
  • Industry report
  • February 2016
  • by Bioseeker

The hot entry of microRNA (miRNA) targeting drugs in oncology may come to revolutionize how we in the near future can launch a highly tumor-specific, multi-targeted attack with minimal toxicities eithe ...

  • Industries : Biological Therapy
Melanoma Global Clinical Trials Review, H1, 2016

Melanoma Global Clinical Trials Review, H1, 2016

  • € 2 000
  • Industry report
  • January 2016
  • by Global Data

Melanoma Global Clinical Trials Review, H1, 2016 Summary GlobalData's clinical trial report, “Melanoma Global Clinical Trials Review, H1, 2016" provides an overview of Melanoma clinical trials scenario. ...

  • Industries : Drug Discovery and Development, Pharmaceutical
  • Countries : World, United States
Sezary Syndrome Global Clinical Trials Review, H1, 2016

Sezary Syndrome Global Clinical Trials Review, H1, 2016

  • € 2 000
  • Industry report
  • January 2016
  • by Global Data

Sezary Syndrome Global Clinical Trials Review, H1, 2016 Summary GlobalData's clinical trial report, “Sezary Syndrome Global Clinical Trials Review, H1, 2016" provides an overview of Sezary Syndrome clinical ...

  • Industries : Pathology
  • Countries : World
Ionis Pharmaceuticals, Inc. - Strategy and SWOT Report

Ionis Pharmaceuticals, Inc. - Strategy and SWOT Report

  • € 140
  • Industry report
  • January 2016
  • by MarketLine

Introduction Ionis Pharmaceuticals, Inc. - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product ...

  • Industries : Pathology
  • Countries : United States
Translational Regenerative Medicine: Market Prospects 2016-2026

Translational Regenerative Medicine: Market Prospects 2016-2026

  • € 2 429
  • Industry report
  • January 2016
  • by Visiongain

Report Details What can be expected from the Translational Regenerative Medicine market? Which areas are going to grow at the fastest rates? This visiongain report shows you potential revenues to 2026, ...

  • Industries : Biological Therapy
  • Countries : World
Translational Regenerative Medicine: Market Prospects 2016-2026: Can Promising Therapies in Stem Cells, Tissue Engineering and Gene Therapy Change the Way We Treat Rare and Chronic Diseases?

Translational Regenerative Medicine: Market Prospects 2016-2026: Can Promising Therapies in Stem Cells, Tissue Engineering and Gene Therapy Change the Way We Treat Rare and Chronic Diseases?

  • € 2 429
  • Industry report
  • January 2016
  • by Visiongain

Report Details What can be expected from the Translational Regenerative Medicine market? Which areas are going to grow at the fastest rates? This visiongain report shows you potential revenues to 2026, ...

  • Industries : Biological Therapy
  • Countries : World
RNAi Technologies and Global Markets

RNAi Technologies and Global Markets

  • € 5 320
  • Industry report
  • January 2016
  • by BCC Research

This BCC Research report summarizes the global RNAi technologies market by category and by region. The RNAi market is analyzed based on RNAi research tools and reagents as well as on RNAi diagnostics. ...

  • Industries : Biological Therapy
  • Countries : World
Cell Analysis Market by Product, by Process, & by End User - Forecast to 2020

Cell Analysis Market by Product, by Process, & by End User - Forecast to 2020

  • € 3 720
  • Industry report
  • January 2016
  • by MarketsandMarkets

The global cell analysis market is expected to reach USD 26.0 billion by 2020 from USD 19.0 billion in 2015, growing at a CAGR of 6.56% from 2015 to 2020. The global cell analysis market is categorized ...

  • Industries : Biological Therapy, Biotechnology
  • Countries : World, Europe, North America
Cell Isolation/Cell Separation Market by Product, Cell Type, Technique, Application  & End user - Forecast to 2020

Cell Isolation/Cell Separation Market by Product, Cell Type, Technique, Application & End user - Forecast to 2020

  • € 3 720
  • Industry report
  • January 2016
  • by MarketsandMarkets

The global cell isolation market is expected to reach USD 6.3 billion by 2020 from USD 2.9 billion in 2015, growing at a CAGR of 16.8% from 2015 to 2020. The global cell isolation market is categorized ...

  • Industries : Biotechnology, Biological Therapy
  • Countries : World, Europe, Asia, North America
International Stem Cell Corporation (ISCO) - Financial and Strategic SWOT Analysis Review

International Stem Cell Corporation (ISCO) - Financial and Strategic SWOT Analysis Review

  • € 240
  • Company report
  • January 2016
  • by Global Data

Summary International Stem Cell Corporation (ISCC) is a biotechnology company that develops technology solutions. The company develops parthenogenesis, a stem cell technology that improves the field of ...

  • Industries : Biological Therapy
Pathfinder Cell Therapy, Inc. (PFND) - Financial and Strategic SWOT Analysis Review

Pathfinder Cell Therapy, Inc. (PFND) - Financial and Strategic SWOT Analysis Review

  • € 240
  • Company report
  • January 2016
  • by Global Data

Summary Pathfinder Cell Therapy, Inc. (Pathfinder) is a regenerative medicine company that develops novel based therapies. The company has discovered a new mammalian cell type which is able to stimulate ...

  • Industries : Biological Therapy, Biopharmaceutical, Biotechnology, Blood Supply, Tissue Banking and Transplantation, Drug Delivery Technology, Drug and Medication
Tissue Therapies Limited (TIS) - Financial and Strategic SWOT Analysis Review

Tissue Therapies Limited (TIS) - Financial and Strategic SWOT Analysis Review

  • € 240
  • Company report
  • January 2016
  • by Global Data

Summary Tissue Therapies Limited (TTL) is a heath biotechnology company that develops, manufactures and markets synthetic proteins. The company develops treatments for acute and chronic wound healing applications ...

  • Industries : Biological Therapy
3D Cell Culture Global Market  – Forecast To 2021

3D Cell Culture Global Market – Forecast To 2021

  • € 3 600
  • Industry report
  • January 2016
  • by IQ4I Research & Consultancy Pvt. Ltd

3D cell culture is accepted as a new dimension of cell culture sector in biomedical research field. Cells grown on two-dimensional (2D) substrates do not represent true in-vivo cell environment and lack ...

  • Industries : Biological Therapy, Diagnostics, Diagnostics, In Vitro Diagnostic, In Vitro Diagnostic, Biotechnology
  • Countries : World
Fibroblast Growth Factor Receptor (FGFR) Agonists -Pipeline Insights, 2016

Fibroblast Growth Factor Receptor (FGFR) Agonists -Pipeline Insights, 2016

  • € 1 000
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “Fibroblast Growth Factor Receptor (FGFR) Agonists-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around ...

  • Industries : Biological Therapy
Fibroblast Growth Factor Receptor (FGFR) Inhibitors -Pipeline Insights, 2016

Fibroblast Growth Factor Receptor (FGFR) Inhibitors -Pipeline Insights, 2016

  • € 1 000
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “Fibroblast Growth Factor Receptor (FGFR) Inhibitors-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around ...

  • Industries : Biological Therapy
Fibroblast Growth Factor Receptor 4 (FGFR4) Inhibitors -Pipeline Insights, 2016

Fibroblast Growth Factor Receptor 4 (FGFR4) Inhibitors -Pipeline Insights, 2016

  • € 1 000
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “Fibroblast Growth Factor Receptor 4 (FGFR4) Inhibitors-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities ...

  • Industries : Biological Therapy
Broad Spectrum Chemokine Inhibitors (BSCIs) -Pipeline Insights, 2016

Broad Spectrum Chemokine Inhibitors (BSCIs) -Pipeline Insights, 2016

  • € 1 000
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “Broad Spectrum Chemokine Inhibitors (BSCIs)-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the ...

  • Industries : Biological Therapy
Anti GM-CSF Antibody -Pipeline Insights, 2016

Anti GM-CSF Antibody -Pipeline Insights, 2016

  • € 1 000
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “Anti GM-CSF Antibody-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Anti GM-CSF Antibody. The ...

  • Industries : Biopharmaceutical, Biotechnology, Biological Therapy
Growth Hormone Antagonists -Pipeline Insights, 2016

Growth Hormone Antagonists -Pipeline Insights, 2016

  • € 1 000
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “Growth Hormone Antagonists-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Growth Hormone Antagonists. ...

  • Industries : Biological Therapy, Biopharmaceutical
Interferon-Alpha/Beta Receptor Binders -Pipeline Insights, 2016

Interferon-Alpha/Beta Receptor Binders -Pipeline Insights, 2016

  • € 1 000
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “Interferon-Alpha/Beta Receptor Binders-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Inte ...

  • Industries : Office Supply and Stationery, Office Goods, Biopharmaceutical, Biological Therapy
Hepatocyte growth factor (HGF) mimetic -Pipeline Insights, 2016

Hepatocyte growth factor (HGF) mimetic -Pipeline Insights, 2016

  • € 1 000
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “Hepatocyte growth factor (HGF) mimetic-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Hepatocyte ...

  • Industries : Biological Therapy
 B-Cell Non-Hodgkin Lymphoma-Pipeline Insights, 2016

B-Cell Non-Hodgkin Lymphoma-Pipeline Insights, 2016

  • € 1 000
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “ B-Cell Non-Hodgkin Lymphoma-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the B-Cell Non-Hodgkin ...

  • Industries : Biological Therapy
Rituxan -Drug Insights, 2016

Rituxan -Drug Insights, 2016

  • € 800
  • Industry report
  • January 2016
  • by Delve Insight

DelveInsight Drug Report, “Rituxan- Drug Insights, 2016” highlights the Rituxan marketed details, pipeline status and the Global API Manufacturers along with the location. The DelveInsight’s report ...

  • Industries : Biological Therapy
  • Countries : World, United States, Europe
Interferon Gamma Receptor (IFNGR) Binders -Pipeline Insights, 2016

Interferon Gamma Receptor (IFNGR) Binders -Pipeline Insights, 2016

  • € 1 000
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “Interferon Gamma Receptor (IFNGR) Binders-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Interferon ...

  • Industries : Office Supply and Stationery, Office Goods, Biological Therapy

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.